How Biophysical Forces Regulate Human B Cell Lymphomas.,
Apoorva, F, Loiben Alexander M., Shah Shivem B., Purwada Alberto, Fontan Lorena, Goldstein Rebecca, Kirby Brian J., Melnick Ari M., Cosgrove Benjamin D., and Singh Ankur
, Cell Rep, 2018 Apr 10, Volume 23, Issue 2, p.499-511, (2018)
ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia.,
Maes, Tamara, Mascaró Cristina, Tirapu Iñigo, Estiarte Angels, Ciceri Filippo, Lunardi Serena, Guibourt Nathalie, Perdones Alvaro, Lufino Michele M. P., Somervaille Tim C. P., et al.
, Cancer Cell, 2018 Mar 12, Volume 33, Issue 3, p.495-511.e12, (2018)
PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.,
Lu, Xiaoqing, Fernando Tharu M., Lossos Chen, Yusufova Nevin, Liu Fan, Fontan Lorena, Durant Matthew, Geng Huimin, Melnick Jacob, Luo Yuan, et al.
, Blood, 2018 Nov 08, Volume 132, Issue 19, p.2026-2039, (2018)
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.,
Fontan, Lorena, Qiao Qi, Hatcher John M., Casalena Gabriella, Us Ilkay, Teater Matt, Durant Matt, Du Guangyan, Xia Min, Bilchuk Natalia, et al.
, J Clin Invest, 2018 Oct 01, Volume 128, Issue 10, p.4397-4412, (2018)